Peter David Suzdak
Direttore/Membro del Consiglio presso Acidophil LLC
Posizioni attive di Peter David Suzdak
Società | Posizione | Inizio | Fine |
---|---|---|---|
Acidophil LLC
Acidophil LLC Medical/Nursing ServicesHealth Services Acidophil LLC develops biotechnologies and products in the field of applied genetics and molecular engineering. It uses synthetic biology and/or synthetic chemistry to apply the lessons of evolution to the discovery and development of novel bioactive compounds and related production processes for a variety of market sectors. The company was founded by Sydney Brenner and Philip Goelet and is headquartered in Lutherville, MD. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Peter David Suzdak
Precedenti posizioni note di Peter David Suzdak
Società | Posizione | Inizio | Fine |
---|---|---|---|
REXAHN PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/06/2013 | 14/11/2018 |
Amministratore Delegato | 31/01/2013 | 14/11/2018 | |
AEOLUS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/06/2004 | 08/05/2013 |
Independent Dir/Board Member | 23/05/2011 | 08/05/2013 | |
Incara Pharmaceuticals Corp. | Direttore/Membro del Consiglio | - | 09/08/2004 |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Direttore Tecnico/Scientifico/R&S | 01/01/2002 | 01/01/2002 |
NOVO NORDISK A/S | Direttore Tecnico/Scientifico/R&S | 01/01/1995 | 01/01/1995 |
National Institute of Mental Health | Direttore Tecnico/Scientifico/R&S | 01/01/1988 | 01/01/1988 |
Corridor Pharmaceuticals, Inc.
Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Direttore Tecnico/Scientifico/R&S | 23/05/2011 | - |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Amministratore Delegato | 01/01/2006 | - |
Fondatore | 31/12/2010 | - | |
Presidente | 31/12/2010 | - | |
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | - | - |
Formazione di Peter David Suzdak
St. John's University | Undergraduate Degree |
University of Connecticut | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Danimarca | 2 |
Posizioni
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Chief Executive Officer | 3 |
Settori
Health Technology | 9 |
Consumer Services | 3 |
Government | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
NOVO NORDISK A/S | Health Technology |
AEOLUS PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 8 |
---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Incara Pharmaceuticals Corp. | Health Technology |
Artesian Therapeutics, Inc.
Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Health Technology |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Rexahn Pharmaceuticals, Inc.
Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
National Institute of Mental Health | Government |
Acidophil LLC
Acidophil LLC Medical/Nursing ServicesHealth Services Acidophil LLC develops biotechnologies and products in the field of applied genetics and molecular engineering. It uses synthetic biology and/or synthetic chemistry to apply the lessons of evolution to the discovery and development of novel bioactive compounds and related production processes for a variety of market sectors. The company was founded by Sydney Brenner and Philip Goelet and is headquartered in Lutherville, MD. | Health Services |
Corridor Pharmaceuticals, Inc.
Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Health Technology |
- Borsa valori
- Insiders
- Peter David Suzdak
- Esperienza